Detalhe da pesquisa
1.
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10388): 1571-1583, 2023 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116523
2.
Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database.
Future Oncol
; 19(2): 159-171, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36912693
3.
Elderly patients with acute myeloid leukemia who only receive supportive care in the Surveillance, Epidemiology and End Results-Medicare database: demographics, treatment patterns and outcomes.
Future Oncol
; 19(24): 1677-1693, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345543
4.
Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy.
Gastroenterology
; 146(2): 442-52.e1, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24126097
5.
Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide.
BMC Cancer
; 13: 121, 2013 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23497336
6.
Low or undetectable TPO receptor expression in malignant tissue and cell lines derived from breast, lung, and ovarian tumors.
BMC Cancer
; 12: 405, 2012 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-22967017
7.
MLL-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy?
Cells
; 8(11)2019 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31671855
8.
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.
Lancet Haematol
; 2(10): e417-26, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26686043